Payer-Specific Negotiated Prices for Prescription Drugs at Top-Performing US Hospitals.
William B Feldman, Benjamin N Rome, Beatrice L Brown, Aaron S Kesselheim
Author Information
- William B Feldman: Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
- Benjamin N Rome: Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
- Beatrice L Brown: Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
- Aaron S Kesselheim: Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
No abstract text available.
- T32 HL007633/NHLBI NIH HHS
Drug Costs
Hospital Costs
Humans
Insurance, Pharmaceutical Services
Pharmacy Service, Hospital
Prescription Drugs
Prescription Fees
United States
